Diabetic Retinopathy Clinical Trials
Diabetic Retinopathy clinical trials are research studies evaluating new treatments, therapies, and approaches for diabetic Retinopathy. Corterve aggregates actively recruiting Diabetic Retinopathy studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility criteria. Participation is always voluntary. This page provides general information and is not medical advice; discuss any trial with your healthcare provider before taking part.
Recruiting Diabetic Retinopathy studies
- Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular EdemaNCT07592273PHASE2, PHASE3AbbViePhoenix, Arizona
- Biomarker of Diabetic RetinopathyNCT05079399Indiana UniversityCarmel, Indiana
- A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic RetinopathyNCT07588100PHASE1Hoffmann-La RocheGlendale, California
- Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein SodiumNCT04008121EARLY_PHASE1MediBeaconAnn Arbor, Michigan
- Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDRNCT06790784PHASE3Jaeb Center for Health ResearchHuntington Beach, California
- Strategies for Improving Linkage-to-Care After Eye Disease ScreeningNCT06943599NAUniversity of California, San FranciscoSan Francisco, California
- Clinical Applications of Advanced Ophthalmic ImagingNCT03135327NAUniversity of MiamiMiami, Florida
- Intraoperative OCT Guidance of Intraocular Surgery IINCT03713268Duke UniversityDurham, North Carolina
- Using Implementation Science to Adapt a Targeted Transportation Intervention for Patients With Diabetic Retinopathy (PRONTO-EYE)NCT07296952NAUniversity of Illinois at ChicagoChicago, Illinois
- Optical Coherence Tomography Angiography in Subjects With Retinal Vascular DiseaseNCT04505618NAJohns Hopkins UniversityBaltimore, Maryland
- Pivotal Trial of Automated Artificial Intelligence (AI) Based System for Early Diagnosis of Diabetic RetinopathyNCT07151001iHealthScreen IncRichmond Hill, New York
- Assessment of AI Program 'DRISTi' as a Screening ToolNCT07222293Artelus AIOxford, North Carolina
Diabetic Retinopathy trials by state
Diabetic Retinopathy trials by metro
Frequently asked questions
- How do I find recruiting Diabetic Retinopathy clinical trials?
- Corterve aggregates actively recruiting Diabetic Retinopathy studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Diabetic Retinopathy clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Diabetic Retinopathy clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.